COMMUNIQUÉS West-GlobeNewswire

RXB Healthcare Technologies Enters European Market with Acquisition of SPR Global Technologies

11/07/2018 - 15:00

VANCOUVER, British Columbia, July 11, 2018 (GLOBE NEWSWIRE) -- RXB Healthcare Technologies Ltd. (the "Company" or "RXB Healthcare") is pleased to announce that it has entered into an agreement to acquire SPR Global [...]

Cure Pharmaceutical Plans to Acquire Cannabinoid-Based Drug Pipeline from Therapix Biosciences Ltd.

11/07/2018 - 14:57

OXNARD, Calif., July 11, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), an innovative drug delivery and development company, announced today that it has signed a term sheet with Therapix [...]

Teladoc to Announce Second Quarter 2018 Financial Results

11/07/2018 - 14:35

PURCHASE, NY, July 11, 2018 (GLOBE NEWSWIRE) -- Teladoc , Inc. (NYSE:TDOC), the global leader in virtual care, announced today that it will release second quarter 2018 results on Wednesday, August 1, 2018, after the [...]

Yield10 Bioscience Names Dr. Jay J. Thelen, Ph.D. to Scientific Advisory Board

11/07/2018 - 14:30

WOBURN, Mass., July 11, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-changes in yield for major food and feed crops to enhance global food [...]

Vilacto Bio Focuses Resources On Pharmaceutical Opportunities for LACTOACTIVE iTHER®

11/07/2018 - 14:30

COPENHAGEN, Denmark, July 11, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTCQB:VIBI) plans to focus on its new pharmaceutical product, LACTOACTIVE iTHER®, as another potential revenue stream for the company along with [...]

Lumiata Raises $11 Million to Accelerate AI Powered Health Analytics for Improving Healthcare, Introduces CEO Dilawar Syed

11/07/2018 - 14:05

Funding from Khosla Ventures, BlueCross BlueShield Venture Partners, and Intel Capital to fuel transformation of healthcare across insurers, providers and employers through predictive analytics SAN MATEO, Calif., July [...]

UroGen Pharma Submits Investigational New Drug (IND) Application for UGN-102 (VesiGel™) for the Treatment of Low-Grade Non-Muscle Invasive Bladder Cancer (LG NMIBC)

11/07/2018 - 14:00

Company Expects to Begin U.S. Phase 2b Clinical Trial in Q3 2018 UGN-102 Has Potential to Become the First Front Line Non-Surgical Therapy for Patients with LG NMIBC RA’ANANA, Israel and NEW YORK, July 11, 2018 (GLOBE [...]

BioSig Technologies to Present at the 40th International Conference of the IEEE Engineering in Medicine and Biology Society

11/07/2018 - 14:00

Research Poster “Unipolar Intracardiac Signal Morphology as a Parameter for Catheter Contact Evaluation” to be presented at EMBC ‘18 on July 18 in Honolulu, Hawaii Santa Monica, CA, July 11, 2018 (GLOBE NEWSWIRE) -- [...]

Melinta Therapeutics to Report Second Quarter 2018 Financial Results on August 7, 2018

11/07/2018 - 14:00

NEW HAVEN, Conn., July 11, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial [...]

Atlant Clinical to receive ISO 9001:2015 certification in Organization and Management of Clinical Trials (issued by Bureau Veritas)

11/07/2018 - 13:50

RIDGEWOOD, N.J., July 11, 2018 (GLOBE NEWSWIRE) -- Atlant Clinical has proven its reputation to be among the world’s top quality CROs by receiving ISO 9001:2015 certification in Organization and Management of Clinical [...]

Moleculin Expands Operations to Australia; Taps R&D Incentive Program Capped at $20,000,000 AUD Turnover

11/07/2018 - 13:30

HOUSTON, July 11, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq:MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]

Corium Announces Issuance of Additional U.S. Patent Covering Corplex™ Donepezil Transdermal System for Alzheimer’s Disease

11/07/2018 - 13:30

Second Orange Book Listable Patent Provides Expanded Coverage to 2037 MENLO PARK, Calif., July 11, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ:CORI), a commercial stage biopharmaceutical company focused [...]

Ovid Therapeutics Announces Initiation of Phase 2 ROCKET Clinical Trial to Evaluate OV101 in Fragile X Syndrome

11/07/2018 - 13:30

Phase 2 trial will evaluate OV101 for 12 weeks in up to 30 males aged 13 to 22 NEW YORK, July 11, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company committed to developing [...]

Akcea and Ionis Announce Approval of TEGSEDI™ (inotersen) in the European Union

11/07/2018 - 13:30

CAMBRIDGE, Mass. and CARLSBAD, Calif., July 11, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), announced [...]

OCHWW looks to the future with appointment of new chief creative officer, Samantha Dolin

11/07/2018 - 13:00

PARSIPPANY, N.J., July 11, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide (OCHWW; www.ogilvychww.com ), a WPP Health & Wellness company (NYSE:WPP) ( www.wpp.com ), announced today that industry-renowned [...]

Asterias Biotherapeutics Announces Positive Outcome from Safety Review Committee for AST-VAC2; Recommends Continuation of Clinical Trial in Non-Small Cell Lung Cancer (NSCLC)

11/07/2018 - 13:00

FREMONT, Calif., July 11, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American:AST), a biotechnology company dedicated to developing cellular immunotherapies to treat cancer and cell-based therapeutics [...]

Cara Therapeutics Announces Dosing of Patients in Phase 2 Trial of Oral KORSUVA™ (CR845/difelikefalin) for Pruritus in Stage III-V Chronic Kidney Disease (CKD) Patients

11/07/2018 - 13:00

Completed Phase 1 trial establishes Oral KORSUVA tablet strengths for treatment of CKD-associated pruritus STAMFORD, Conn., July 11, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical [...]

EyePoint Pharmaceuticals Announces Data Highlighting YUTIQ™ for Posterior Segment Uveitis to be Presented at the 36th Annual Scientific Meeting of the American Society of Retina Specialists

11/07/2018 - 13:00

WATERTOWN, Mass., July 11, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today [...]

Codexis Appoints Dr. Hicham Alaoui, Veteran Drug Discoverer, as Vice President, Biotherapeutics Research & Development

11/07/2018 - 13:00

REDWOOD CITY, Calif., July 11, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces the appointment of Hicham Alaoui, Ph.D. to the newly created position of Vice [...]